All In MedTech

Device Trial Radar · NCT06834334

Clinical Effectiveness of Advanced Hybrid Closed-loop Systems for Achieving Time in Tight Range Among T1D Patients

Clinical Effectiveness of Advanced Hybrid Closed-loop Systems (AHCL) for Achieving Time in Tight Range (TiTR) of Interstitial Glucose Among Adult Type 1 Diabetes (T1D) Patients

Last checked: Nov 19, 2026Latest source record: Mar 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

189

Actual

Start

Feb 27, 2025

Primary completion

Oct 1, 2025

Study completion Oct 1, 2025

Sponsor

Lead sponsor
Castilla-La Mancha Health ServiceAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Servicio Extremeño de Salud (Spain); Hospital Mutua de Terrassa
First posted
Feb 19, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications. Therefore, the key to prevent and/or reduce the development of these chronic complications lies in an adequate and strict glycemic control. This study consist of a cross-sectional observational study among adult patients with type 1 diabetes (T1D). The main objective is to analyze the effect on time in tight range (TiTR, 70-140 mg/dL) of interstitial glucose between three different advanced hybrid closed-loop (AHCL) systems.

Conditions

  • Type 1 Diabetes (T1D)

Interventions

  • MM780GDevice

    SmartGuard in Medtronic Minimed 780G advaced hybrid closed-loop

  • TTSX2Device

    Control-IQ in Tandem T Slim X2 advanced hybrid closed-loop

  • CamAPSDevice

    CamAPS Fx in Ypsopump advanced hybrid closed-loop

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TiTRTime frame: Retrospective data from the last 14 days after study entry

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Badajoz University Hospital

    Badajoz, Badajoz, Spain

  • Hospital Universitario Mutua de Tarrasa

    Terrassa, Barcelona, Spain

  • Ciudad Real General University Hospital

    Ciudad Real, Ciudad Real, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.